Managing the innovation supply chain to maximize personalized medicine

Clinical Pharmacology and Therapeutics

Volumn 95, Issue 2, 2014, Pages 113-118

  Waldman, S A ^a,b   Terzic, A ^c  

^a Delaware Valley Institute for Clinical and Translational Science   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFUSION OF INNOVATION; DRUG DISCOVERY; HEALTH POLICY; HUMANS; INDIVIDUALIZED MEDICINE; INVENTIONS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84893792465     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.228     Document Type: Review

References (23)

1. Waldman, S.A. & Terzic, A. Systems-based discovery advances drug development. Clin. Pharmacol. Ther. 93, 285-287 (2013).
2. Evans, W.E., Crews, K.R. & Pui, C.H. A health-care system perspective on implementing genomic medicine: Pediatric acute lymphoblastic leukemia as a paradigm. Clin. Pharmacol. Ther. 94, 224-229 (2013).
3. Waldman, S.A. & Terzic, A. Information hierarchies optimize patient-centered solutions. Clin. Pharmacol. Ther. 93, 3-7 (2013).
4. Gonzalez de Castro, D., Clarke, P.A., Al-Lazikani, B. & Workman, P. Personalized cancer medicine: Molecular diagnostics, predictive biomarkers, and drug resistance. Clin. Pharmacol. Ther. 93, 252-259 (2013).
5. Jacunski, A. & Tatonetti, N.P. Connecting the dots: Applications of network medicine in pharmacology and disease. Clin. Pharmacol. Ther. 94, 659-669 (2013).
6. Lewis, J.P., Yerges-Armstrong, L.M., Ellero-Simatos, S., Georgiades, A., Kaddurah-Daouk, R. & Hankemeier, T. Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy. Clin. Pharmacol. Ther. 94, 570-573 (2013).
7. Roden, D.M. & Tyndale, R.F. Genomic medicine, precision medicine, personalized medicine: what's in a name Clin. Pharmacol. Ther. 94, 169-172 (2013).
8. Johnson, J.A., Klein, T.E. & Relling, M.V. Clinical implementation of pharmacogenetics: More than one gene at a time. Clin. Pharmacol. Ther. 93, 384-385 (2013).
9. Waldman, S.A. & Terzic, A. The value proposition of molecular medicine. Clin. Transl. Sci. 5, 108-110 (2012).
10. Waldman, S.A. & Terzic, A. Knowledge cycle transforms therapeutic innovation. Clin. Pharmacol. Ther. 91, 3-8 (2012).
11. Waldman, S.A. & Terzic, A. Translational medicine individualizes healthcare discovery, development and delivery. Foreword. Biomark. Med. 7, 1-3 (2013).
12. Waldman, S.A., van der Graaf, P.H. & Terzic, A. Systems approaches evolve clinical pharmacology. CPT Pharmacometrics Syst. Pharmacol. 2, e68 (2013).
13. Harland, C.M. Supply chain management, purchasing and supply management, logistics, vertical integration, materials management, and supply chain dynamics. In: Blackwell Encyclopedia Dictionary of Operations Management (ed. Slack, N.) (Blackwell, Oxford, UK, 1996).
14. Lu, W.J. & Flockhart, D.A. Personal DNA donation to energize genomic medicine. Clin. Pharmacol. Ther. 95, 129-131 (2014).
15. Whirl-Carrillo, M. et al. Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 92, 414-417 (2012).
16. Kesselheim, A.S. & Shiu, N. The evolving role of biomarker patents in personalized medicine. Clin. Pharmacol. Ther. 95, 127-129 (2014).
17. Kaddurah-Daouk, R. & Weinshilboum, R.M. Pharmacometabolomics: Implications for clinical pharmacology and systems pharmacology. Clin. Pharmacol. Ther. 95, 154-167 (2014).
18. James, L.P. Metabolomics: Integration of a new "omics" with clinical pharmacology. Clin. Pharmacol. Ther. 94, 547-551 (2013).
19. Krauss, R.M., Zhu, H. & Kaddurah-Daouk, R. Pharmacometabolomics of statin response. Clin. Pharmacol. Ther. 94, 562-565 (2013).
20. Robertson, D.G. & Frevert, U. Metabolomics in drug discovery and development. Clin. Pharmacol. Ther. 94, 559-561 (2013).
21. Shin, K.H., Choi, M.H., Lim, K.S., Yu, K.S., Jang, I.J. & Cho, J.Y. Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance. Clin. Pharmacol. Ther. 94, 601-609 (2013).
22. Momper, J.D. & Wagner, J.A. Therapeutic drug monitoring as a component of personalized medicine: Applications in pediatric drug development. Clin. Pharmacol. Ther. 95, 138-140 (2014).
23. Selker, H.P. et al. A proposal for integrated efficacy-toeffectiveness (E2E) clinical trials. Clin. Pharmacol. Ther. 95, 147-153 (2014).